title: Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection.
authors.affiliation: Emergency Department, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
authors.forename: Bo
authors.initials: B
authors.lastname: Zhang
authors.forename: Marc
authors.initials: M
authors.lastname: Fila
authors.forename: May
authors.initials: M
authors.lastname: Fakhoury
authors.forename: Véronique
authors.initials: V
authors.lastname: Baudouin
authors.forename: Georges
authors.initials: G
authors.lastname: Deschênes
authors.forename: Evelyne
authors.initials: E
authors.lastname: Jacqz-Aigrain
authors.forename: Wei
authors.initials: W
authors.lastname: Zhao
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D003404:Creatinine / Q000652:urine; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy*; D016903:Drug Monitoring; D015774:Ganciclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000494:pharmacology; D006801:Humans; D007223:Infant; D009404:Nephrotic Syndrome / Q000150:complications*; D011507:Proteinuria; D016896:Treatment Outcome; D014556:Urine / Q000737:chemistry; D000077562:Valganciclovir; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D003404:Creatinine; D000077562:Valganciclovir; D015774:Ganciclovir
keywords: dosage optimization; paediatric pharmacokinetics; paediatric pharmacology; therapeutic drug monitoring